Concepedia

Publication | Open Access

Characterization of CD33/CD3 Tetravalent Bispecific Tandem Diabodies (TandAbs) for the Treatment of Acute Myeloid Leukemia

DOIFull Paper Access

89

Citations

23

References

2016

Year

Uwe Reusch, Kimberly H. Harrington, Chelsea J. Gudgeon, Ivica Fucek, Kristina Ellwanger, Michael Weichel, Stefan Knackmuss, Eugene A. Zhukovsky, Judith A. Fox, Lori Kunkel,
Clinical Cancer Research

Abstract

Our data show high efficacy of CD33/CD3 TandAbs in various preclinical models of human AML. Together, these findings support further study of CD33/CD3 TandAbs as novel immunotherapeutics for patients with AML. Clin Cancer Res; 22(23); 5829-38. ©2016 AACR.

References

YearCitations

Page 1